Monarch Partners Asset Management LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 210 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$4,163,444
-18.9%
62,327
+4.6%
1.23%
-20.2%
Q3 2022$5,131,000
+23.5%
59,584
+28.0%
1.54%
+32.8%
Q2 2022$4,155,000
+18.7%
46,568
+35.8%
1.16%
+252.9%
Q3 2016$3,499,00034,2800.33%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders